Xu Zekuan, Wang Linjun, Li Zheng. Lymph node dissection strategy of adenocarcinoma of esophagogastric junction[J]. Chinese Journal of Digestive Surgery, 2021, 20(6): 631-634. DOI: 10.3760/cma.j.cn115610-20210322-00141
Citation: Xu Zekuan, Wang Linjun, Li Zheng. Lymph node dissection strategy of adenocarcinoma of esophagogastric junction[J]. Chinese Journal of Digestive Surgery, 2021, 20(6): 631-634. DOI: 10.3760/cma.j.cn115610-20210322-00141

Lymph node dissection strategy of adenocarcinoma of esophagogastric junction

  • The incidence of adenocarcinoma of esophagogastric junction (AEG) is on the rise. Due to its special lesion location and biological behavior, AEG is considered as a relatively independent disease by more and more scholars, which is different from esophageal cancer or gastric cancer. AEG is anatomically located at the junction of esophagus and stomach. The lymph node metastasis of AEG can be directed to the mediastinal and abdominal. At present, the rule of lymph node metastasis of AEG is not completely clear, and the scope of lymph node dissection has not reached a consensus. The authors summarize the hot issues and clinical evidence of lymph node dissection for AEG, in order to provide references for more reasonable lymph node dissection of AEG.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return